查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| STX Seagate Technology Holdings PLC Ordinary Shares (Ireland) | 35.81 2027-06-30 | 32.06 – 41.89 | 20 | +25.26% | +31.67% | +36.28% | 5 / 0 | $18.81B |
| TX Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) | 5.89 2026-12-31 | 5.45 – 6.11 | 3 | +10.45% | +22.30% | +61.80% | 2 / 1 | $17.34B |
| TXN Texas Instruments Incorporated Common Stock | 8.5 2026-12-31 | 8.08 – 8.71 | 25 | +9.35% | +10.85% | +10.69% | 29 / 0 | $21.9B |
| GNTX Gentex Corporation Common Stock | 2.1 2026-12-31 | 2.06 – 2.15 | 6 | +4.90% | +5.16% | +5.16% | 1 / 0 | $2.67B |
| RTX RTX Corporation Common Stock | 7.19 2026-12-31 | 6.64 – 7.4 | 23 | +3.01% | +3.98% | +4.06% | 2 / 0 | $96.06B |
| TVTX Travere Therapeutics Inc. Common Stock | 1.88 2026-12-31 | 0.92 – 2.86 | 7 | +0.46% | +2.66% | +13.38% | 2 / 2 | $680.2M |
| TGTX TG Therapeutics Inc. Common Stock | 1.57 2026-12-31 | 1.3 – 1.82 | 6 | -2.51% | +2.42% | +33.73% | 2 / 0 | $942.51M |
| NUTX Nutex Health Inc. Common Stock | 21.52 2026-12-31 | 15.2 – 24.37 | 5 | +1.41% | +2.38% | +15.30% | 2 / 0 | $880.37M |
| MTX Minerals Technologies Inc. Common Stock | 6.28 2026-12-31 | 6.1 – 6.55 | 4 | +0.08% | +0.97% | +1.33% | 0 / 1 | $2.2B |
| TXRH Texas Roadhouse Inc. Common Stock | 6.43 2026-12-31 | 6.15 – 6.81 | 27 | +0.06% | +0.21% | +2.15% | 2 / 0 | $6.54B |
| GATX GATX Corporation Common Stock | 10.04 2026-12-31 | 9.96 – 10.1 | 4 | 0.00% | -0.01% | +0.21% | 2 / 1 | $2.39B |
| TXT Textron Inc. Common Stock | 6.46 2026-12-31 | 6 – 6.6 | 17 | -0.70% | -0.78% | -0.49% | 0 / 2 | $15.57B |
| VRTX Vertex Pharmaceuticals Incorporated Common Stock | 18.98 2026-12-31 | 17.61 – 19.85 | 20 | +0.07% | -0.88% | -0.61% | 14 / 10 | $13.05B |
| TRTX TPG RE Finance Trust Inc. Common Stock | 1.03 2026-12-31 | 1 – 1.07 | 4 | -1.91% | -1.44% | -2.01% | 0 / 1 | $106.37M |
| MKTX MarketAxess Holdings Inc. Common Stock | 7.94 2026-12-31 | 7.4 – 8.27 | 10 | +0.17% | -1.70% | -3.77% | 0 / 2 | $892.78M |
| TXNM TXNM Energy Inc. Common Stock | 2.94 2026-12-31 | 2.84 – 3.08 | 5 | -2.09% | -2.09% | +2.02% | 0 / 1 | $2.33B |
| AMTX Aemetis Inc. (DE) Common Stock | -0.9 2026-12-31 | -1.12 – -0.68 | 3 | — | — | — | 0 / 1 | $279.38M |
| AVTX Avalo Therapeutics Inc. Common Stock | -2.56 2026-12-31 | -3.53 – -1.77 | 11 | — | — | — | 5 / 0 | $0 |
| BDTX Black Diamond Therapeutics Inc. Common Stock | -0.63 2026-12-31 | -0.96 – -0.1 | 6 | — | — | — | 2 / 3 | $5.56M |
| BNTX BioNTech SE American Depositary Share | -4.28 2026-12-31 | -5.85 – -3.3 | 8 | — | — | — | 3 / 2 | $2.17B |
| CATX Perspective Therapeutics Inc. Common Stock | -1.12 2026-12-31 | -1.37 – -0.96 | 8 | — | — | — | 4 / 1 | $423.17K |
| CGTX Cognition Therapeutics Inc. Common Stock | -0.32 2026-12-31 | -0.44 – -0.26 | 4 | — | — | — | 3 / 1 | $0 |
| CNTX Context Therapeutics Inc. Common Stock | -0.39 2026-12-31 | -0.43 – -0.3 | 8 | — | — | — | 6 / 1 | $0 |
| DFTX Definium Therapeutics Inc. Common Shares | -2.2 2026-12-31 | -2.67 – -1.85 | 13 | — | — | — | 2 / 2 | $0 |
| ELTX Elicio Therapeutics Inc. Common Stock | -2.07 2026-12-31 | -2.3 – -1.82 | 4 | — | — | — | 1 / 0 | $0 |
| EWTX Edgewise Therapeutics Inc. Common Stock | -0.23 2026-12-31 | -2.34 – 8.31 | 6 | — | — | — | 1 / 0 | $209.38M |
| FHTX Foghorn Therapeutics Inc. Common Stock | -1.06 2026-12-31 | -1.57 – -0.7 | 8 | — | — | — | 0 / 0 | $25.84M |
| IMTX Immatics N.V. Ordinary Shares | -1.94 2026-12-31 | -2.22 – -1.24 | 8 | — | — | — | 2 / 7 | $46.86M |
| KYTX Kyverna Therapeutics Inc. Common Stock | -2.88 2026-12-31 | -3.03 – -2.59 | 5 | — | — | — | 2 / 2 | $0 |
| LCTX Lineage Cell Therapeutics Inc. Common Stock | -0.07 2026-12-31 | -0.14 – 0.04 | 5 | — | — | — | 1 / 1 | $17.94M |
| MGTX MeiraGTx Holdings plc Ordinary Shares | -1.44 2026-12-31 | -2.39 – -0.52 | 6 | — | — | — | 3 / 0 | $49.34M |
| MLTX MoonLake Immunotherapeutics Class A Ordinary Shares | -3.8 2026-12-31 | -5.16 – -2.9 | 9 | — | — | — | 1 / 1 | $0 |
| NBTX Nanobiotix S.A. American Depositary Shares | -0.13 2026-12-31 | -0.6 – 0.63 | 3 | — | — | — | 0 / 0 | $38.06M |
| NKTX Nkarta Inc. Common Stock | -1.48 2026-12-31 | -1.6 – -1.4 | 3 | — | — | — | 1 / 0 | $0 |
| OSTX OS Therapies Incorporated Common Stock | -0.78 2026-12-31 | -1.04 – -0.45 | 3 | — | — | — | 0 / 2 | $0 |
| SINT SiNtx Technologies Inc. Common Stock | -2.14 2026-12-31 | -2.27 – -2 | 3 | — | — | — | 0 / 1 | $2.3M |
| SPTX Seaport Therapeutics Inc. Common Stock | -5.11 2026-12-31 | -12.07 – -2.8 | 5 | — | — | — | 0 / 0 | $0 |
| STXS Stereotaxis Inc. Common Stock | -0.19 2026-12-31 | -0.23 – -0.17 | 3 | — | — | — | 0 / 1 | $39.4M |
| VKTX Viking Therapeutics Inc. Common Stock | -4.61 2026-12-31 | -5.35 – -3.81 | 15 | — | — | — | 2 / 11 | $0 |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。